Interaction of Crohn's disease susceptibility genes in an Australian paediatric cohort

Josef Wagner1, Winnie H Sim, Justine A Ellis

  • 1Enteric Virus Group, Murdoch Childrens Research Institute, Melbourne, Victoria, Australia. josef.wagner@mcri.edu.au

Plos One
|November 17, 2010
PubMed

Insights

Genetic susceptibility plays a key role in Crohn's disease (CD) pathogenesis. This study identified significant gene associations and interactions in Australian pediatric CD patients, revealing complex genetic underpinnings.

Area of Science:

  • Genetics
  • Gastroenterology
  • Pediatrics

Background:

  • Genetic susceptibility is a significant factor in Crohn's disease (CD) development.
  • Understanding the genetic basis of pediatric CD is crucial for early diagnosis and treatment.
  • Previous studies have identified several CD susceptibility genes, but their roles in early-onset disease require further investigation.

Purpose of the Study:

  • To investigate multiple CD susceptibility genes in an Australian pediatric CD cohort.
  • To identify specific single nucleotide polymorphisms (SNPs) and gene-gene interactions associated with pediatric CD.
  • To explore the relationship between genetic factors and disease phenotypes in young CD patients.

Main Methods:

  • Genotyping of 34 single nucleotide polymorphisms (SNPs) in 18 genetic loci in 72 pediatric CD patients and 98 controls.
  • Performing gene-gene interaction analysis, gene-disease phenotype analysis, and genetic risk profiling.
  • Analyzing associations between specific SNPs, genes, and CD status, including disease location.

Main Results:

  • Four polymorphisms in three genes (NOD2, IL23R, 3p21) were significantly associated with CD status (p<0.05).
  • An additive gene-gene interaction was identified involving TLR4, PSMG1, TNFRSF6B, and IRGM.
  • Genes involved in microbial processing (TLR4, PSMG1, NOD2) showed significant individual or interactive associations with CD.
  • Specific SNPs and variants were associated with colonic or ileal/colonic disease, with some novel findings in pediatric CD.

Conclusions:

  • This study demonstrates significant genetic associations with Crohn's disease in a pediatric onset cohort.
  • Several identified genetic associations have not been previously reported in pediatric CD patients.
  • Pediatric CD genetic susceptibility arises from a complex interplay of multiple genes and their interactions.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...